UPDATE 1-Allergan, Richter's bipolar depression drug succeeds key trial
December 18, 2017 at 08:58 AM EST
Dec 18 (Reuters) - Allergan Plc and Hungary's Gedeon Richter Plc said on Monday their drug to treat severe bipolar depression in adults met the main goal of a late-stage study, bringing the them closer to getting another approval for the drug.
